01:59 PM EST - Algernon Pharmaceuticals Inc : Announced they have granted 96,000 stock options exercisable at $4.10 for five years from date of grant, for officers and directors, employees and a consultant and are subject to approval by regulatory authorities. Algernon is a drug re-purposing company that investigates safe, already approved drugs, including naturally occurring compounds, for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon Pharmaceuticals Inc
shares C.AGN are trading unchanged at $4.10.
